These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 38617509)
1. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma. Zhang H; Cao C; Xiong H Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509 [TBL] [Abstract][Full Text] [Related]
2. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma. Chen M; Wang X; Wang W; Gui X; Li Z Front Immunol; 2022; 13():829057. PubMed ID: 35833114 [TBL] [Abstract][Full Text] [Related]
3. Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma. Wang X; Luo X; Wang Z; Wang Y; Zhao J; Bian L Heliyon; 2023 Sep; 9(9):e19114. PubMed ID: 37662825 [TBL] [Abstract][Full Text] [Related]
4. Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma. Hou S; Xu H; Liu S; Yang B; Li L; Zhao H; Jiang C Front Genet; 2022; 13():860268. PubMed ID: 35464867 [TBL] [Abstract][Full Text] [Related]
5. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma. Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X Front Genet; 2022; 13():975905. PubMed ID: 36313456 [No Abstract] [Full Text] [Related]
6. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Xu Q; Xu H; Chen S; Huang W Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040 [No Abstract] [Full Text] [Related]
7. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
8. mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers. Zhang Y; Tseng JT; Lien IC; Li F; Wu W; Li H Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121037 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses. Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of immune escape-related genes in lung adenocarcinoma. Jia HR; Li WC; Wu L Transl Cancer Res; 2024 Jun; 13(6):2647-2661. PubMed ID: 38988926 [TBL] [Abstract][Full Text] [Related]
11. Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes. He J; Li W; Li Y; Liu G Transl Cancer Res; 2020 May; 9(5):3518-3538. PubMed ID: 35117717 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma. Zhang M; Wang X; Chen X; Guo F; Hong J Front Genet; 2020; 11():441. PubMed ID: 32431729 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis of an immunotherapy responsiveness-related gene signature in predicting lung adenocarcinoma prognosis. Jiang Y; Hammad B; Huang H; Zhang C; Xiao B; Liu L; Liu Q; Liang H; Zhao Z; Gao Y Transl Lung Cancer Res; 2024 Jun; 13(6):1277-1295. PubMed ID: 38973963 [TBL] [Abstract][Full Text] [Related]
14. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Li Y; Zheng P; Zhan X Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015 [TBL] [Abstract][Full Text] [Related]
15. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer. Zhao X; Lin J Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313 [TBL] [Abstract][Full Text] [Related]
16. A ferroptosis-related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study. Dong J; Tao T; Yu J; Shan H; Liu Z; Zheng G; Li Z; Situ W; Zhu X; Li Z Cancer Rep (Hoboken); 2024 Jan; 7(1):e1925. PubMed ID: 38043920 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape. Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X Front Oncol; 2023; 13():1199608. PubMed ID: 37409245 [TBL] [Abstract][Full Text] [Related]
18. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis. Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746 [TBL] [Abstract][Full Text] [Related]
19. A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma. Xu H; Zou R; Liu J; Zhu L J Oncol; 2021; 2021():6653247. PubMed ID: 33747079 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma. Lin L; Zhang W Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]